Trial Profile
Treatment Switch From Efavirenz to Rilpivirine in Virologically-suppressed HIV-infected Thai Adolescents
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Rilpivirine (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 16 Feb 2017 Results (n=20) presented at the 24th Conference on Retroviruses and Opportunistic Infections
- 03 Feb 2017 New trial record